Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAGBiotechnology
+$2.32 today
- Market cap
- $1.83B
- Beta
- 0.00
Volume 0.30M
Average 0.34M
COAG Total Non-current Assets
All assets not expected to be converted to cash within one year.
Hemab Therapeutics Holdings, Inc. Common StockNASDAQ: COAG
Total Non-current Assets · Q2 FY2026 · quarter ended Jun 2026
Total non-current assets of $3.78M in Q2 FY2026
Q2 FY2026 total non-current assets was $3.78M.
Context
- Total non-current assets amounted to 0.8% of total assets at the end of Q2 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 2.23M USD
- Year-over-year change
- —
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.23M | — |
Total Non-current Assets vs competitors
How COAG compares with its peers on the latest reported figures
- COAG's Jun 2026 total non-current assets of $3.78M is the 2nd highest of the 5 companies compared; the peer median is $1.53M.
- Total non-current assets amounts to 0.8% of total assets for COAG, versus a peer median of 1.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $162.96M | -4.1% | -9.5% | 20.9% | |
COAGHemab Therapeutics Holdings, Inc. Common Stock | Jun 2026 | $3.78M | — | — | 0.8% |
IRONDisc Medicine, Inc. | Sep 2026 | $2.08M | -36.6% | +20.3% | 0.3% |
| Mar 2026 | $982K | +63.1% | +2.4% | 1.8% | |
DMRADamora Therapeutics, Inc. | Mar 2026 | $34K | -98.3% | -77.6% | 0.0% |
| Peer median (excluding COAG) | $1.53M | -20.4% | -3.6% | 1.1% | |
Competitors are the stored peer set for COAG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG
Intrinsic Alpha fair value
Locked
Current Price
$39.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.